Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Effects of Phosphodiesterase Inhibitors on Contraction Induced by Endothelin-1 of Isolated Human Prostatic Tissue
Urology, 07/02/09
Kedia GT et al. - The results have provide additional evidence that the function of prostatic smooth muscle is under the control of peptidergic and cyclic nucleotide (cyclic guanosine monophosphate, cyclic adenosine monophosphate)-mediated pathways. This might give a rationale for the use of drugs interacting with cyclic guanosine monophosphate or cyclic adenosine monophosphate signaling, such as PDE inhibitors or nitric oxide donors, in the pharmacotherapy of the benign prostatic syndrome.
Related Articles
Platelet Cyclic Guanosine Monophosphate as a Biomarker of Phosphodiesterase Type 5 Inhibitor Efficacy in the Treatment of Erectile Dysfunction: A Randomized Placebo-Controlled Study
European Urology, 11/05/09
Relevance Score: 67%%
Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
Annals of Internal Medicine, 10/23/09
Relevance Score: 67%%
Erectile Dysfunction: Treatment With Oral Medications Demonstrates Significant Improvements In Sexual Intercourse And Erectile Function
ScienceDaily, 10/20/09
Relevance Score: 66%%
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09
Relevance Score: 65%%
Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine
Therapeutic Advances in Urology, 10/08/09
Relevance Score: 65%%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
CD10 expression in urothelial carcinoma of the bladder
Diagnostic Pathology, 11/20/09
Increased Prevalance of the -211 T Allele of Follicle Stimulating Hormone (FSH)beta Subunit Promoter Polymorphism and Lower Serum FSH in Infertile Men
Journal of Clinical Endocrinology and Metabolism, 11/20/09
DNA Replication Licensing Factors and Aneuploidy Are Linked to Tumor Cell Cycle State and Clinical Outcome in Penile Carcinoma
Clinical Cancer Research, 11/20/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research, 11/20/09
Extended-Release Doxazosin for Treatment of Renal Transplant Recipients With Benign Prostatic Hyperplasia
Transplantation Proceedings, 11/20/09
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
European Journal of Endocrinology, 11/19/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Examination of polymorphic glutathione s-transferase (gst) genes, tobacco smoking and prostate cancer risk among men of african descent: A case-control study
BMC Cancer, 11/20/09
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research, 11/20/09
Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
Clinical Cancer Research, 11/20/09
Article Search
Sponsor


See Latest Articles


